- Title
- Anticoagulant activity in Australasian elapid snake venoms and neutralisation with antivenom and varespladib.
- Creator
- Murphy, Kate; Tasoulis, Theo; Dunstan, Nathan; Isbister, Geoffrey K.
- Relation
- NHMRC.1154503
- Relation
- Toxicon Vol. 247, Issue 28 August 2024, no. 107836
- Publisher Link
- http://dx.doi.org/10.1016/j.toxicon.2024.107836
- Publisher
- Elsevier
- Resource Type
- journal article
- Date
- 2024
- Description
- The venoms of Australasian elapid snakes are known to possess coagulant activity, including some with strong procoagulant activity and others with anticoagulant activity, although the latter are less well known. This study investigates the anticoagulant activity of Australasian elapid snake venoms, and whether this activity is neutralised by commercial snake antivenom and varespladib (PLA2 inhibiting agent). Clotting assays were completed for 34 species of Australasian elapids. Antivenom neutralisation assays with tiger snake antivenom (TSAV) were performed on five species to determine if there was cross-neutralisation. Varespladib neutralisation assays were also completed for the same five species. All Pseudechis species venoms had anticoagulant activity, except P. porphyriacus, which was procoagulant. Pseudechis species venoms had similar anticoagulant potency ranging from the most potent P. colletti venom to the least potent P. butleri venom. The three Austrelaps (copperhead) species venoms were the next most potent anticoagulants. Six further snakes, Elapognathus coronatus, Acanthophis pyrrhus, A. antarcticus, Suta suta, Denisonia devisi and D. maculata, had weaker anticoagulant activity, except for D. maculata which had similar anticoagulant activity to Pseudechis species. Tiger Snake Antivenom (1200mU/mL) neutralised the anticoagulant effect of P. australis for concentrations up to 1 mg/mL. TSAV (1200mU/mL) also neutralised P. colletti, D. maculata, A. superbus and A. pyrrhus venoms at their EC50, demonstrating cross neutralisation. Varespladib neutralised the anticoagulant effect of P. australis venom at 5μM and for venoms of P. colletti, D. maculata, A. superbus and A. pyrrhus. We found anticoagulant activity to be present in six genera of Australasian snakes at low concentrations, which can be completely neutralised by both antivenom and varespladib. Anticoagulant activity in Australian elapid venoms was associated with species possessing high PLA2 activity without procoagulant snake venom serine proteases.
- Subject
- snake; venom; anticoagulant; toxin; phospholipase; varespladib; antivenom
- Identifier
- http://hdl.handle.net/1959.13/1509595
- Identifier
- uon:56269
- Identifier
- ISSN:0041-0101
- Rights
- x
- Language
- eng
- Reviewed
- Hits: 31
- Visitors: 31
- Downloads: 0